Both Retatrutide and Wegovy are new medications created for treating type 2 diabetes and encouraging weight reduction . However, they operate through slightly different mechanisms . copyright is a GLP-1 receptor site activator , while Retatrutide acts as a dual GIP and GLP-1 activator , possibly